L. Brown

发表

The use of the Goldberg Indices with alcoholics: a cautionary note.

E. Chaney, M. Schuckit, M. O'leary, 1978, Journal of clinical psychology.

Rates of tuberculosis infection in healthcare workers providing services to HIV-infected populations. Terry Beirn Community Programs for Clinical Research on AIDS.

W. El-Sadr, F. Gordin, J. Matts, 1998, Infection control and hospital epidemiology.

Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network.

E. Bini, J. Rotrosen, R. Goldsmith, 2006, Journal of substance abuse treatment.

Variation among state-level approaches to addressing alcohol abuse in opioid treatment programs.

S. Strauss, M. Parrino, L. Brown, 2010, Journal of substance abuse treatment.

Alcohol Education Provided to Opioid Treatment Program Patients: Results of a Nationwide Survey

D. Rindskopf, S. Strauss, M. Parrino, 2010, Journal of drug education.

Effect of psychological factors on risk behavior of human immunodeficiency virus (HIV) infection among intravenous drug users (IVDUs).

L. Brown, T. Nemoto, K. Foster, 1991, The International journal of the addictions.

Heterosexual transmission of human immunodeficiency virus among intravenous drug users.

R. Pickens, R. Battjes, Z. Amsel, 1990, The Journal of infectious diseases.

Evaluation of an Electronic Medical Record System at an Opioid Agonist Treatment Program

L. Brown, Steven A Kritz, R. Zavala, 2014, Journal of addiction medicine.

Electronic medical record system at an opioid agonist treatment programme : study design , pre-implementation results and post-implementation trendsjep

L. Brown, Steven A Kritz, Melissa Chu, 2012 .

Electronic medical record system at an opioid agonist treatment programme: study design, pre-implementation results and post-implementation trends.

L. Brown, Steven A Kritz, Melissa Chu, 2012, Journal of evaluation in clinical practice.

Post-traumatic stress disorder among inner city methadone maintenance patients.

T. J. Meyer, L. Brown, R. E. Villagómez, 1995, Journal of substance abuse treatment.

Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.

E. Bini, D. Alderson, J. Rotrosen, 2012, Journal of substance abuse treatment.

Evidence for Response Set Effects in Structured Research Interviews

A. Alterman, J. Cacciola, L. Brown, 1996, The Journal of nervous and mental disease.

Addiction Severity Index scores of four racial/ethnic and gender groups of methadone maintenance patients.

A. Alterman, J. Cacciola, L. Brown, 1993, Journal of substance abuse.

Drug abuse treatment programs as centers for HIV-related research and treatment.

M. Hickson, L. Brown, P. Lee, 1993, Journal of addictive diseases.

Rates of Tuberculosis Infection in Healthcare Workers Providing Services to HIV-Infected Populations

W. El-Sadr, Elizabeth B Finley, F. Gordin, 1998, Infection Control & Hospital Epidemiology.

Drug abuse, HIV infection, and tuberculosis.

L. Brown, C. Felton, 1989, JAMA.

Enrollment of drug abusers in HIV clinical trials: a public health imperative for communities of color.

L. Brown, 1993, Journal of psychoactive drugs.

No seroconversions among steady sex partners of methadone‐maintained HIV‐1-seropositive injecting drug users in New York City

R. Makuch, L. Brown, N. Siddiqui, 1992, AIDS.

Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program.

M. Markatou, A. Talal, S. Dickerson, 2019, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

HIV/AIDS policies and sports: the National Football League.

L. Brown, C. Brown, R. Phillips, 1994, Medicine and science in sports and exercise.

The New York policy on smoking in addiction treatment: findings after 1 year.

D. Ziedonis, J. Guydish, A. Bostrom, 2012, American journal of public health.

Opioid Dependence as a Chronic Disease: The Interrelationships Between Length of Stay, Methadone Dose, and Age on Treatment Outcome at an Urban Opioid Treatment Program

L. Brown, Steven A Kritz, Melissa Chu, 2009, Journal of addictive diseases.

Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention

A. Talal, R. Dimova, L. Brown, 2016, Journal of addiction medicine.

Endocrine complications of AIDS and drug addiction.

F. Singer, L. Brown, P. Killian, 1991, Endocrinology and metabolism clinics of North America.

Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.

W. Blattner, Helen H. Lee, S. Weiss, 1990, The Journal of infectious diseases.

Conflicting measurements of depression in a substance abuse population.

A. Alterman, L. Brown, A. Zaballero, 1993, Journal of substance abuse.

Changes in locus-of-control attitudes about drug misuse in a self-help group in a methadone maintenance clinic.

D. Nurco, L. Brown, B. Primm, 1995, The International journal of the addictions.

HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.

R. Pickens, R. Battjes, L. Brown, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent.

D. Metzger, A. Alterman, P. Mcdermott, 1998 .

Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

T. Louis, N. Kimmel, W. El-Sadr, 1994, JAMA.

A multicomponent model for substance abuse treatment. The Addiction Research and Treatment Corporation.

L. Brown, A. Zaballero, H. Batson, 1992, Journal of Substance Abuse Treatment.

Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.

P. Narang, L. Brown, R. Li, 1996, Drug and alcohol dependence.

Drug treatment and HIV seropositivity.

L. Brown, B. Primm, W. Burkett, 1988, New York state journal of medicine.

Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City.

T. J. Meyer, T. Meyer, V. González, 1993, Journal of psychoactive drugs.

Toward precision prescribing for methadone: Determinants of methadone deposition

M. Markatou, E. Kharasch, C. Venuto, 2020, PloS one.

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

W. Ling, S. Batki, J. Renner, 1998, Addiction.

Appropriate Use of Drug Testing in Clinical Addiction Medicine.

Lewis S. Nelson, M. Hurford, Dawn L. Lindsay, 2017, Journal of addiction medicine.

Interviewer severity ratings and composite scores of the ASI: a further look.

J. McKay, A. Alterman, L. Brown, 1994, Drug and alcohol dependence.

Smoking Behaviors and Attitudes Among Clients and Staff at New York Addiction Treatment Programs Following a Smoking Ban: Findings After 5 Years.

K. Delucchi, J. Guydish, L. Brown, 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

W. El-Sadr, R. Hafner, F. Gordin, 1997, The New England journal of medicine.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Jeffrey J. Annon, Thomas E. Freese, W. Ling, 2004, The American journal on addictions.

Sexual risk behaviour among subgroups of heterosexual HIV infected patients in an urban setting.

J. Feldman, H. Minkoff, J. Dehovitz, 1997, Genitourinary medicine.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

W. Ling, L. Amass, J. Annon, 2009, Drug and alcohol dependence.

Substance abuse treatment as HIV prevention: more questions than answers.

E. Bini, D. Alderson, J. Rotrosen, 2010, Journal of the National Medical Association.

Health Services for HIV/AIDS, HCV, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

E. Bini, D. Alderson, J. Rotrosen, 2007, Public health reports.

Two-stage tuberculin skin testing in individuals with human immunodeficiency virus infection

C. Salveson, K. Muth, F. Gordin, 1995 .

Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders.

M. Markatou, G. Cloherty, A. Talal, 2017, Journal of substance abuse treatment.

Disparities in Health Services for HIV/AIDS, Hepatitis C Virus, and Sexually Transmitted Infections: Role of Substance Abuse Treatment Programs

E. Bini, D. Alderson, J. Rotrosen, 2009, Journal of addiction medicine.

NIDA’s Clinical Trials Network: An Opportunity for HIV Research in Community Substance Abuse Treatment Programs

S. Shoptaw, G. Woody, L. Metsch, 2011, The American journal of drug and alcohol abuse.

Methadone-maintenance outcomes for Hispanic and African-American men and women.

A. Cnaan, A. Alterman, J. Cacciola, 1999, Drug and alcohol dependence.

Construct refinement and confirmation for the Addiction Severity Index.

J. McKay, A. Alterman, P. Mcdermott, 1996 .

New scales to assess change in the Addiction Severity Index for the opioid, cocaine, and alcohol dependent.

D. Metzger, A. Alterman, P. Mcdermott, 1998 .

Title NIDA ' s clinical trials network : An opportunity for HIV research in community substance abuse treatment programs

S. Shoptaw, L. Metsch, B. Schackman, 2011 .

Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States

D. Alderson, J. Rotrosen, L. Brown, 2011, Journal of addictive diseases.

States and substance abuse treatment programs: funding and guidelines for infection-related services.

E. Bini, D. Alderson, J. Rotrosen, 2008, American journal of public health.

Personality Assessment Inventory (PAI) Scores of Lower-Socioeconomic African American and Latino Methadone Maintenance Patients

A. Alterman, P. Mcdermott, L. Brown, 1995 .

Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus (HCV) Management in Opioid Use Disorder Patients on Methadone.

M. Markatou, A. Talal, L. Brown, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Needle sharing and AIDS in minorities.

L. Brown, B. Primm, D. Murphy, 1987, Journal of the American Medical Association (JAMA).

Drug use patterns: implications for the acquired immunodeficiency syndrome.

L. Brown, B. Primm, D. Murphy, 1986, Journal of the National Medical Association.

Addressing ethnic disparities in drug abuse treatment in the clinical trials network

K. Carroll, Carmen L Rosa, L. Brown, 2007 .

The validity of the interviewer severity ratings in groups of ASI interviewers with varying training.

A. Cnaan, A. Alterman, P. Mcdermott, 2001, Addiction.

Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioral, and clinical features.

L. Brown, B. Primm, T. Nemoto, 1989, New York state journal of medicine.

Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.

H. Lee, L. Brown, T. Nemoto, 1991, New York state journal of medicine.

Short-term declines in CD4 levels associated with cocaine use in HIV-1 seropositive, minority injecting drug users.

R. Makuch, L. Brown, N. Siddiqui, 1993, Journal of the National Medical Association.

Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users.

L. Brown, N. Siddiqui, A. Chu, 1996, Journal of the National Medical Association.

Nicotine dependence and depression among methadone maintenance patients.

T. J. Meyer, L. Brown, M. Lin, 1996, Journal of the National Medical Association.

Substance Abuse Treatment Clinician Opinions and Infectious Disease Service Delivery

Michael Levy, E. Bini, D. Alderson, 2009, Journal of addictive diseases.

Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.

L. Brown, Melissa Chu, Charles Madray, 2006, Journal of substance abuse treatment.